Self-Assessment and Performance in Practice Modules

Presented by The American Headache Society

American Headache Society's®
Self-Assessment and Performance in Practice Modules

Welcome to the American Headache Society’s® Self-Assessment and Performance in Practice (PIP) Modules.

Self-Assessment and Performance in Practice (PIP) activities are required for the American Board of Psychiatry and Neurology (ABPN) Maintenance of Certification. Self-Assessment activities cover knowledge and/or “best-practices” in one or more competency areas and provide feedback that can be used as the basis for focused Continuing Medical Education (CME), lifelong learning, and/or career development. PIP is a quality improvement activity for “clinically-active” physicians to assess their current practice patterns, compare those practice patterns to a set of “best-practices”, participate in educational activities to improve one’s practice, and then re-evaluate one’s practice following the educational interventions.

Hardware/Software Requirements

Contact AHS

If you have any questions about this course please contact AHS headquarters at ahshq@talley.com or 856-423-0043.

Policy on Privacy and Confidentiality

View the American Headache Society's Policy on Privacy and Confidentiality

 

Available Courses

Project1

2014Scottsdale_940x129-compressed

 

 

Comprehensive Migraine Education Program (CMEP) Self-Assessment and Performance in Practice Modules

These PIP and Self-Assessment modules focus on migraine, with a special focus on chronic migraine. Migraine is a common neurologic disorder affecting 18% of women and 6% of men in the United States. Long considered a chronic disorder with a stable course, recent research demonstrates that in a subgroup, migraine progresses from a pattern of less frequent headaches (termed ‘episodic migraine’) to very frequent headaches (termed ‘chronic migraine’); a condition with a population prevalence of about 2%. These Self-Assessment and PIP modules aim to assess your knowledge and clinical performance regarding the diagnosis and treatment of migraine patients, and then provide educational activities aimed at enhancing your knowledge-base and clinical skills.

The entire activity (Self Assessment and Performance in Practice Modules) will take about 22 hours of your time, commensurate with the total number of CME credits provided.

Assessment and education cover the following topics:

  • Secondary Headaches
  • Diagnosing Primary Headaches
  • Medication Overuse
  • Migraine Co-Morbidities
  • Headache-Related Disability
  • Acute Treatment of Migraine
  • Prophylactic Treatment of Migraine
  • Migraine Triggers
  • Non-Pharmacologic Treatment of Migraine
  • Quantitative Assessment of Headache Patterns

The Self-Assessment module consists of 25 multiple choice questions about migraine and related disorders. After completing the test, you will be provided with the correct answers and links to educational materials pertinent to each question.

The PIP module consists of three stages:

  • Stage A – Initial Assessment

    Collect and enter data from 10 of your patients who presented with a chief complaint of headache and were diagnosed with migraine. Receive feedback regarding your performance in evaluating and treating these patients.
  • Stage B – Educational Interventions

    Education will include lectures, videos, podcasts, published papers, and links to resources that you can use with your patients. Complete recommended educational interventions within 3 months of completing Stage A.
  • Stage C – Follow-Up Assessment

    Complete this stage within 3 months of completing stage B. Collect and enter data from 10 of your patients who presented with a chief complaint of headache and were diagnosed with migraine. These patients must have been evaluated after completion of Stage B. Receive feedback regarding your performance in evaluating and treating these patients.

Curriculum Developers

Richard Lipton, MD, FAHS
Professor and Vice Chair of Neurology
Professor of Epidemiology and Population Health
Albert Einstein College of Medicine
Bronx, NY

Todd J. Schwedt, MD, FAHS
Associate Professor
Department of Neurology
Mayo Clinic Arizona
Phoenix, AZ

Faculty

Todd J. Schwedt, MD, FAHS
Associate Professor
Department of Neurology
Mayo Clinic Arizona
Phoenix, AZ

Ethics Committee

Chair

Sylvia Lucas, MD, PhD, FAHS
University of Washington Medical Center
Seattle, WA

Andrew C. Charles, MD, FAHS
University of California - Los Angeles
Los Angeles, CAS

Robert B. Daroff, MD, FAHS
Case Western Reserve University
Cleveland, OH

Michael Moskowitz, MD, FAHS
Massachusetts General Hospital
Charlestown, MA

Bert B. Vargas, MD, FAHS
Mayo Clinic Arizona
Phoenix, AZ

Sarah Vollbracht, MD
Montefiore Headache Center
Bronx, NY

Board of Directors

President
Lawrence C. Newman, MD, FAHS
The Headache Institute
New York, NY
Member-at-Large
Andrew C. Charles, MD, FAHS
University of California, Los Angeles
Los Angeles, CA
Member-at-Large
Bert B. Vargas, MD, FAHS
Mayo Clinic Arizona
Phoenix, AZ
Past President Advisor
Robert B. Daroff, MD, FAHS
Case Western Reserve University
Cleveland, OH
Immediate Past President
Elizabeth W. Loder, MD, MPH, FAHS
John R. Graham Headache Center
Boston, MA

Member-at-Large/Legislative Liaison
Deborah I. Friedman, MD, MPH, FAHS
University of Texas Southwestern
Dallas, TX

Chair of the Special Interest Sections
Sheena K. Aurora, MD, FAHS
Stanford University
Palo Alto, CA
Past President Advisor
Richard B. Lipton, MD, FAHS
Albert Einstein College of Medicine
Bronx, NY
President-Elect/IHS Representative
R. Allan Purdy, MD, FAHS
Dalhousie University
Halifax, NS, Canada
Member-at-Large
Andrew D. Hershey, MD, PhD, FAHS
Cincinnati Children’s Hospital Medical Center
Cincinnati, OH
Chair of the American Migraine Foundation
David W. Dodick, MD, FAHS
Mayo Clinic Arizona
Phoenix, AZ
Past President Advisor
Stephen D. Silberstein, MD, FAHS
Jefferson Headache Center
Philadelphia, PA
Treasurer
Kathleen B. Digre, MD, FAHS
University of Utah Salt Lake City, UT
Member-at-Large
Michael A. Moskowitz, MD, FAHS
Massachusetts General Hospital
Charlestown, MA
Editor of the Journal
Thomas N. Ward, MD, FAHS
Dartmouth Hitchcock Medical Center
Lebanon, NH
Past President Advisor
Paul Winner, DO, FAHS
Palm Beach Headache Center
West Palm Beach, FL
Secretary
Peter J. Goadsby, MD, PhD, FAHS
University of California, San Francisco
San Francisco, CA
Member-at-Large
Todd J. Schwedt, MD, MSCI, FAHS
Mayo Clinic Arizona Phoenix, AZ
Corporate Liaison
Barry S. Baumel, MD
University of Miami
Miami, FL
Pan Asian Liaison
Fumihiko Sakai, MD
Saitama International Headache Center
Saitama, Japan
Member-at-Large/Pan American Liaison
Werner J. Becker, MD, FAHS
University of Calgary
Calgary, AB, Canada
Member-at-Large
Robert E. Shapiro, MD, PhD, FAHS
University of Vermont
Burlington, VT
Legislative Liaison
Joel R. Saper, MD, FAHS Michigan Head Pain and Neurological Institute
Ann Arbor, MI
Chief Executive Officer
Linda McGillicuddy
American Headache Society
Mt. Royal, NJ

Disclosure Statement

All contributors who can affect American Headache Society CME content (including Leadership, program chairs, moderators, faculty members, medical writers and staff), in their respective roles, are required to disclose all relevant financial relationships with any commercial interest that could be viewed as a real or perceived conflict of interest.  Contributors will also identify relevant financial relationships of their spouse.

This policy is in effect to maintain adherence with the conflict of interest guidelines set by the Accreditation Council for Continuing Medical Education (ACCME) and the American Headache Society Ethics Committee.

Attendees will be made aware of any affiliation or relevant financial interest that may affect the development, management, presentation or evaluation of the CME activity and will be printed in the final program and projected in slide format before each presentation.  Individuals who refuse to disclose relevant financial relationships will be disqualified from being a contributor, and cannot have control of, or responsibility for, the development, management, presentation or evaluation of the CME activity. 

Curriculum Developer Disclosures

Richard B. Lipton, MD, FAHS - Dr. Lipton receives research support from the NIH- PO1 AG03949 (Program Director), PO1AG027734 (Project Leader), RO1AG025119 (Investigator), K23AGO30857 (Mentor), K23NS05140901A1 (Mentor), and K23NS47256 (Mentor), the National Headache Foundation and the Migraine Research Fund; serves on the editorial boards of Neurology and Cephalalgia and as senior advisor to Headache, has reviewed for the NIA and NINDS, holds stock options in Neuralieve Inc, and Minster INC; serves as a consultant or has received honoraria from: Allergan, Autonomic Technologies, Boston Scientific, Bristol Myers Squibb, Eli Lilly, Endo, GlaxoSmithKline, Minster, Merck, Nautilus Neuroscience, Neuralieve, Novartis, and Pfizer.

Todd Schwedt, MD, FAHS - Dr. Schwedt is the recipient of research grants from AGA Medical and Merck & Co., Inc. He is on the speaker's bureau for Allergan.

Faculty Disclosures

Todd Schwedt, MD, FAHS - Dr. Schwedt is the recipient of research grants from AGA Medical and Merck & Co., Inc. He is on the speaker's bureau for Allergan.

Ethics Committee Disclosures

Andrew C. Charles, MD, FAHS
Dr. Charles has received consulting fees and/or honoraria from American Headache Society, Amgen, eNeura, and AGA Medical.

Robert B. Daroff, MD, FAHS
Dr. Daroff has nothing to disclose.

Sylvia Lucas, MD, PhD, FAHS
Dr. Lucas has received research grants from Allergan, Amgen, and Kineta.

Michael Moskowitz, MD, FAHS
Dr. Moskowitz has equity interest/stock options in Miotech.

Bert B. Vargas, MD, FAHS
Dr. Vargas has nothing to disclose.

Sarah Vollbracht, MD
Dr. Vollbracht has nothing to disclose.

Board of Directors Disclosures

View the Board of Directors Disclosures

Staff Disclosures

Linda McGillicuddy
Ms. McGillicuddy has nothing to disclose.

Andrea Taylor
Ms. Taylor has nothing to disclose.

Kathy  Baumer
Ms. Baumer has nothing to disclose.

Maripat Traino
Ms. Traino has nothing to disclose.

Laurie Morris
Ms. Morris has nothing to disclose.

ABPN Approved

The Comprehensive Migraine Education Program (CMEP) Performance Improvement (PICME) has been reviewed and approved by the American Board of Psychiatry and Neurology (ABPN). The approval period is for April 14, 2014 - April 14, 2017. Twenty category-1 CME credits are awarded after completion of the PIP module and two category-1 CME credits are awarded following completion of the Self-Assessment module. This project fulfills the clinical module of a Performance in Practice Unit.

Continuing Medication Education (CME) Credits

The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing education medical education for physicians. The American Headache Society takes responsibility for the content, quality, and scientific integrity of this CME activity.

The American Headache Society® designates AMA PRA Category 1 credit(s)TM for this online, web-based medical education activity, Comprehensive Migraine Education Program (CMEP)  Self-Assessment and Performance in Practice Modules. A maximum of 2 CME credits are awarded upon completion of this Self-Assessment program and a maximum of 20 CME credits are awarded upon completion of the PIP program.

Activity Start Date: October 19, 2011

Activity End Date: April 14, 2014

American Academy of Physician Assistants (AAPA)

This Performance Improvement CME program has been reviewed and is approved for a maximum of 20.00 AAPA Category 1 PI-CME credits by the Physician Assistant Review Panel. Total number of approved credits for each stage of this PI-CME program are as follows:

  • Stage A: 5.0 AAPA Category 1 PI-CME credits
  • Stage B: 5.0 AAPA Category 1 PI-CME credits
  • Stage C: 5.0 AAPA Category 1 PI-CME credits
  • Bonus for completion of all three stages: 5.0 AAPA Category 1 PI-CME credits

Approval is valid until October 19, 2014. Physician Assistants should claim only the credit commensurate with the extent of their participation in the activity. This program was planned in accordance with AAPA’s CME Standards. Please note the Self Assessment module is not approved for AAPA Category 1 Self-Assessment credits.

Note

The outcomes from these Self-Assessment and PIP modules will be collected in order to determine the effectiveness of this initiative and for development of future versions of this Self-Assessment and PIP module. Furthermore, these outcomes (in aggregate) may be reported. However, all data would be de-identified prior to reporting/publication.

 

Supported by an educational grant from Allergan_(color)

 

CLICK HERE TO TAKE THIS COURSE

 


2014 Scottsdale Headache Symposium® Self-Assessment and Performance in Practice Modules

This Self-Assessment module focuses on headache, including both primary and secondary headache disorders, and consists of 100 multiple-choice questions. Participants must take the pre-test prior to attending the 2014 Scottsdale Headache Symposium.  Participants will take the post-test after the Symposium, and obtain a minimum passing score of 70% on the post-test to receive CME credit.  After completing the pre-test, the correct answers and links to educational materials pertinent to each question will be provided.

The entire activity (Self Assessment and Performance in Practice Modules) will take about 28 hours of your time, commensurate with the total number of CME credits provided.

Assessment and education cover the following topics:

  • Secondary Headaches
  • Diagnosing Primary Headaches
  • Inpatient Headache Management
  • Migraine Epidemiology
  • Migraine Pathophysiology
  • Trigeminal Autonomic Cephalalgias
  • Medication Overuse
  • Migraine Co-Morbidities
  • Headache-Related Disability
  • Acute Treatment of Migraine
  • Prophylactic Treatment of Migraine
  • Quantitative Assessment of Headache Patterns
  • High and Low Pressure Headache
  • Neuroimaging Headache
  • Complementary and Alternative Headache Treatments
  • Stroke Guidelines in Women
  • Migraine Management During Pregnancy
  • Hormones and Headache
  • Headaches in Children

The Self-Assessment module consists of 100 multiple choice questions about migraine and related disorders. After completing the test, you will be provided with the correct answers and links to educational materials pertinent to each question.

Performance in Practice (PIP)

The PIP module focuses on the diagnosis and management of migraine, one of the most common reasons a patient will present to a primary care provider or neurologist, and a topic of extensive discussion at the Scottsdale Headache Symposium. Migraine is a prevalent neurologic disorder affecting 18% of women and 6% of men in the United States. Long considered a chronic disorder with a stable course, recent research demonstrates that in a subgroup, migraine progresses from a pattern of less frequent headaches (termed ‘episodic migraine’) to very frequent headaches (termed ‘chronic migraine’); a condition with a population prevalence of about 2%. This PIP module aims to assess your clinical performance when diagnosing and treating migraine patients and provides educational activities regarding migraine.

The PIP module consists of three stages:

  • Stage A – Initial Assessment

    Collect and enter data from 10 of your patients who presented with a chief complaint of headache and were diagnosed with migraine. Receive feedback regarding your performance in evaluating and treating these patients.
  • Stage B – Educational Interventions

    Education will include attendance and participation at the 2014 Scottsdale Headache Symposium.
  • Stage C – Follow-Up Assessment

    Complete this stage within 3 months of completing stage B. Collect and enter data from 10 of your patients who presented with a chief complaint of headache and were diagnosed with migraine. These patients must have been evaluated after completion of Stage B. Receive feedback regarding your performance in evaluating and treating these patients.

Program Committee

Symposium Director
Sheena K. Aurora, MD, FAHS
Stanford University
Palo Alto, CA
 
Symposium Committee
K.C. Brennan, MD, FAHS
University of Utah
Salt Lake City, UT
 
Juline Bryson, MD

The Headache Institute
New York, NY

Rashmi B. Halker, MD, FAHS
Mayo Clinic Arizona
Phoenix, AZ

Scott C. Litin, MD, FAHS
Mayo Clinic Rochester
Rochester, MN

Rebecca Wells, MD, MPH
Wake Forest University
Winston-Salem, NC

Faculty

Jessica Ailani, MD, FAHS
Georgetown University Hospital
Washington, DC
Deborah I. Friedman, MD, MPH, FAHS
UT Southwestern Medical Center
Dallas, TX
Michael J. Marmura, MD, FAHS
Thomas Jefferson University Hosptital
Philadelphia, PA
Huma Sheikh, MD
Brigham and Women’s Hospital
Boston, MA
Felipe Albuquerque, MD
Barrow Neurological Institute
Phoenix, AZ
Amy Gelfand, MD
University of California - San Francisco
San Francisco, CA
Vincent T. Martin, MD, FAHS
University of Cincinnati
Cincinnati, OH
Stephen D. Silberstein, MD, FAHS
Jefferson Headache Center
Philadelphia, PA
Steve M. Baskin, PhD
New England Center for Headache
Stamford, CT
Stacy Girard, MBA, CPC
Mayo Clinic Arizona
Phoenix, AZ
Maureen Ann Moriarty, DNP, APRN
Georgetown University Hosptital
Washington, DC
Amaal Starling, MD
Mayo Clinic Arizona
Phoenix, AZ
Dale S. Bond, PhD
Virginia Commonwealth University
Richmond, VA
Peter J. Goadsby, MD, PhD, FAHS
University of California - San Francisco
San Francisco, CA
Michael Moskowitz, MD, FAHS
Massachusetts General Hospital
Charlestown, MA
Cynthia Stonnington, MD
Mayo Clinic Arizona
Phoenix, AZ
K.C. Brennan, MD, FAHS
University of Utah
Salt Lake City, UT
David J. Gullen, MD
Mayo Clinic Arizona
Phoenix, AZ
Kent Nelson, MD
Mayo Clinic Phoenix
Phoenix, AZ
Deborah Tepper, MD
Cleveland Clinic
Cleveland, OH
Juline Bryson, MD
The Headache Institute
New York, NY
Rashmi B. Halker, MD, FAHS
Mayo Clinic Arizona
Phoenix, AZ
Michael Oshinsky, PhD
Jefferson Headache Center
Philadelphia, PA
Stewart J. Tepper, MD, FAHS
Cleveland Clinic Foundation
Cleveland, OH
Dawn C. Buse, PhD, FAHS
Albert Einstein College of Medicine
Bronx, NY
Andrew D. Hershey, MD, PhD, FAHS
Cincinnati Children’s Hospital
Medical Center
Cincinncati, OH
Neil Parikh, MD, MBA
VA West Los Angeles Medical Center
Los Angeles, CA
Gretchen Tietjen, MD
University of Toledo
Toledo, OH
Andrew C. Charles, MD, FAHS
University of California - Los Angeles
Los Angeles, CA
Susan Hutchinson, MD
Orange County Migraine
& Headache Center
Irvine, CA
B. Lee Peterlin, DO, FAHS
Johns Hopkins University
Baltimore, MD
Bert B. Vargas, MD, FAHS
Mayo Clinic Arizona
Phoenix, AZ
Larry Charleston IV, MD, FAHS
University of Michigan
Ann Arbor, MI
Alvin E. Lake III, PhD, FAHS
Michigan Head Pain
& Neurological Institute
Ann Arbor, MI
Scott W. Powers, PhD, ABPP, FAHS
Cincinnati Children’s Hospital Medical Center
Cincinnati, OH
Thomas N. Ward, MD, FAHS
Dartmouth-Hitchcock Medical Center
Lebabon, NH
Priyanka Chaudhry, MD
UT Southwestern Medical Center
Dallas, TX
Morris Levin, MD, FAHS
University of California - San Francisco
San Francisco, CA
Tamara Pringsheim, MD
University of Calgary
Calgary, AB, Canada
Eric Wassermann, MD
National Institutes of Health /
National Institute of Neurological Disorders and Stroke
Bethesda, MD
Remy Coeytaux, MD
Duke University
Cary, NC
Richard B. Lipton, MD, FAHS
Albert Einstein College of Medicine
Bronx, NY
Matthew S. Robbins, MD, FAHS
Montefiore Headache Center
New York, NY
Rebecca Wells, MD, MPH
Wake Forest University
Winston-Salem, NC
Joshua M. Cohen, MD, MPH
The Headache Institute
New York, NY
Scott C. Litin, MD, FAHS
Mayo Clinic Rochester
Rochester, MN
Jack Schim, MD, FAHS
The Headache Center
of Southern California
Encinitas, CA
Paul Winner, DO, FAHS
Palm Beach Headache Center
West Palm Beach, FL
F. Michael Cutrer, MD
Mayo Clinic Rochester
Rochester, NY
Elizabeth W. Loder, MD, MPH, FAHS
John R. Graham Headache Center
Boston, MA
Todd J. Schwedt, MD, MSCI, FAHS
Mayo Clinic Arizona
Phoenix, AZ
Marcy E. Yonker, MD, FAHS
Phoenix Children’s Hospital
Phoenix, AZ
David W. Dodick, MD, FAHS
Mayo Clinic Arizona
Phoenix, AZ
Sylvia Lucas, MD, PhD, FAHS
University of Washington Medical Center
Seattle, WA
   

 

Ethics Committee

Chair

Sylvia Lucas, MD, PhD, FAHS
University of Washington Medical Center
Seattle, WA

Andrew C. Charles, MD, FAHS
University of California - Los Angeles
Los Angeles, CAS

Robert B. Daroff, MD, FAHS
Case Western Reserve University
Cleveland, OH

Michael Moskowitz, MD, FAHS
Massachusetts General Hospital
Charlestown, MA

Bert B. Vargas, MD, FAHS
Mayo Clinic Arizona
Phoenix, AZ

Sarah Vollbracht, MD
Montefiore Headache Center
Bronx, NY

Board of Directors

President
Lawrence C. Newman, MD, FAHS
The Headache Institute
New York, NY
Member-at-Large
Andrew C. Charles, MD, FAHS
University of California, Los Angeles
Los Angeles, CA
Member-at-Large
Bert B. Vargas, MD, FAHS
Mayo Clinic Arizona
Phoenix, AZ
Past President Advisor
Robert B. Daroff, MD, FAHS
Case Western Reserve University
Cleveland, OH
Immediate Past President
Elizabeth W. Loder, MD, MPH, FAHS
John R. Graham Headache Center
Boston, MA

Member-at-Large/Legislative Liaison
Deborah I. Friedman, MD, MPH, FAHS
University of Texas Southwestern
Dallas, TX

Chair of the Special Interest Sections
Sheena K. Aurora, MD, FAHS
Stanford University
Palo Alto, CA
Past President Advisor
Richard B. Lipton, MD, FAHS
Albert Einstein College of Medicine
Bronx, NY
President-Elect/IHS Representative
R. Allan Purdy, MD, FAHS
Dalhousie University
Halifax, NS, Canada
Member-at-Large
Andrew D. Hershey, MD, PhD, FAHS
Cincinnati Children’s Hospital Medical Center
Cincinnati, OH
Chair of the American Migraine Foundation
David W. Dodick, MD, FAHS
Mayo Clinic Arizona
Phoenix, AZ
Past President Advisor
Stephen D. Silberstein, MD, FAHS
Jefferson Headache Center
Philadelphia, PA
Treasurer
Kathleen B. Digre, MD, FAHS
University of Utah Salt Lake City, UT
Member-at-Large
Michael A. Moskowitz, MD, FAHS
Massachusetts General Hospital
Charlestown, MA
Editor of the Journal
Thomas N. Ward, MD, FAHS
Dartmouth Hitchcock Medical Center
Lebanon, NH
Past President Advisor
Paul Winner, DO, FAHS
Palm Beach Headache Center
West Palm Beach, FL
Secretary
Peter J. Goadsby, MD, PhD, FAHS
University of California, San Francisco
San Francisco, CA
Member-at-Large
Todd J. Schwedt, MD, MSCI, FAHS
Mayo Clinic Arizona Phoenix, AZ
Corporate Liaison
Barry S. Baumel, MD
University of Miami
Miami, FL
Pan Asian Liaison
Fumihiko Sakai, MD
Saitama International Headache Center
Saitama, Japan
Member-at-Large/Pan American Liaison
Werner J. Becker, MD, FAHS
University of Calgary
Calgary, AB, Canada
Member-at-Large
Robert E. Shapiro, MD, PhD, FAHS
University of Vermont
Burlington, VT
Legislative Liaison
Joel R. Saper, MD, FAHS Michigan Head Pain and Neurological Institute
Ann Arbor, MI
Chief Executive Officer
Linda McGillicuddy
American Headache Society
Mt. Royal, NJ

 

Disclosure Statement

All contributors who can affect American Headache Society CME content (including Leadership, program chairs, moderators, faculty members, medical writers and staff), in their respective roles, are required to disclose all relevant financial relationships with any commercial interest that could be viewed as a real or perceived conflict of interest.  Contributors will also identify relevant financial relationships of their spouse.

This policy is in effect to maintain adherence with the conflict of interest guidelines set by the Accreditation Council for Continuing Medical Education (ACCME) and the American Headache Society Ethics Committee.

Attendees will be made aware of any affiliation or relevant financial interest that may affect the development, management, presentation or evaluation of the CME activity and will be printed in the final program and projected in slide format before each presentation.  Individuals who refuse to disclose relevant financial relationships will be disqualified from being a contributor, and cannot have control of, or responsibility for, the development, management, presentation or evaluation of the CME activity. 

Program Committee Disclosures

Sheena K. Aurora, MD, FAHS
Dr. Aurora has received consulting fees and/or honoraria from Merck, Nupathe, eNeura, and Allergan, Inc.  Dr. Aurora is also on all of their speaker bureaus.

K.C. Brennan, MD, FAHS
Dr. Brennan has received consulting fees and/or honoraria from Allergan, Inc. He is a recipient of research grants from Electrocore.

Juline Bryson, MD
Dr. Bryson has nothing to disclose.

Rashmi B. Halker, MD, FAHS
Dr. Halker has nothing to disclose.

Scott C. Litin, MD, FAHS
Dr. Litin has nothing to disclose.

Rebecca Wells, MD, MPH
Dr. Wells has nothing to disclose.

Faculty Disclosures

View the Faculty Disclosures

Ethics Committee Disclosures

Andrew C. Charles, MD, FAHS
Dr. Charles has received consulting fees and/or honoraria from American Headache Society, Amgen, eNeura, and AGA Medical.

Robert B. Daroff, MD, FAHS
Dr. Daroff has nothing to disclose.

Sylvia Lucas, MD, PhD, FAHS
Dr. Lucas has received research grants from Allergan, Amgen, and Kineta.

Michael Moskowitz, MD, FAHS
Dr. Moskowitz has equity interest/stock options in Miotech.

Bert B. Vargas, MD, FAHS
Dr. Vargas has nothing to disclose.

Sarah Vollbracht, MD
Dr. Vollbracht has nothing to disclose.

Staff Disclosures

Linda McGillicuddy
Ms. McGillicuddy has nothing to disclose.

Andrea Taylor
Ms. Taylor has nothing to disclose.

Cheryl Gallagher
Ms. Gallagher has nothing to disclose.

Maripat Traino
Ms. Traino has nothing to disclose.

Elizabeth Frye
Ms. Frye has nothing to disclose.

Renee Wolf
Ms. Wolf has nothing to disclose.

ABPN Approved

The Comprehensive Migraine Education Program (CMEP) Performance Improvement (PICME) has been reviewed and approved by the American Board of Psychiatry and Neurology (ABPN). The approval period is for November 20, 2014 - November 23, 2014. Twenty category-1 CME credits are awarded after completion of the PIP module and eight category-1 CME credits are awarded following completion of the Self-Assessment module. This project fulfills the clinical module of a Performance in Practice Unit.

Continuing Medication Education (CME) Credits

The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing education medical education for physicians. The American Headache Society takes responsibility for the content, quality, and scientific integrity of this CME activity.

The American Headache Society® designates AMA PRA Category 1 credit(s)TM for this online, web-based medical education activity, 2014 Scottsdale Headache Symposium Self-Assessment and Performance in Practice Modules. A maximum of 8 CME credits are awarded upon completion of this Self-Assessment program and a maximum of 20 CME credits are awarded upon completion of the PIP program.

Activity Start Date: October 1, 2014

Activity End Date: September 30, 2016

Note

The outcomes from these Self-Assessment and PIP modules will be collected in order to determine the effectiveness of this initiative and for development of future versions of this Self-Assessment and PIP module. Furthermore, these outcomes (in aggregate) may be reported. However, all data would be de-identified prior to reporting/publication.

CLICK HERE TO TAKE THIS COURSE